Transcatheter arterial embolization for Osteoarthritis
This trial is designed to see if a new treatment for OA is safe and works. People with OA will have a procedure to block blood flow to the knee, and then be followed for 12 months.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many participants are being recruited for this research project?
"Affirmative, the clinicaltrial.gov records indicate that this trial is actively searching for participants. Initially posted on December 1st 2020, it was last modified on November 25th 2022 and seeks 29 patients from one medical facility."
Are there any opportunities for new participants to join this clinical trial?
"Affirmative. The clinicaltrials.gov website demonstrates that this trial is still open for recruitment, having been posted on December 1st 2020 and last modified November 25th 2022. 29 subjects are needed at a single research site."
Is this particular experiment open to patients aged 55 and older?
"Consistent with the guidelines of this medical trial, prospective patients must be between 30 and 80 years old to qualify for involvement."
How can I contribute to this medical experiment?
"This clinical experiment is seeking 29 people afflicted with arthrosis, of any gender, between the ages of 30 and 80. The Kellgren-Lawrence Grade must be 2, 3 or 4 (if there are no bony deformities). Participants should have experienced knee pain for a minimum of three months which has been resistant to conventional treatments such as anti-inflammatory drugs and physical therapy .The severity of discomfort needs to be moderate to severe as determined by a visual analogue scale score greater than 40 out 0f 100. Lastly, all candidates need to display mental competency in order to provide informed consent while being able complete study questionnaires written"
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- NYU Langone Health: < 48 hours